Ausgabe 5/2003
Inhalt (7 Artikel)
Pharmacokinetics of Pegylated Liposomal Doxorubicin
Alberto Gabizon, Hilary Shmeeda, Yechezkel Barenholz
Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress
Edzard Schwedhelm, Renke Maas, Raphael Troost, Rainer H. Böger
No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers
Linda C. Johansson, Magnus Andersson, Gunnar Fager, David Gustafsson, Ulf G. Eriksson
No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran
Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, Mia Svensson, Ulf G. Eriksson
Aminoglycoside Dosages and Nephrotoxicity
Florent Rougier, Michel Ducher, Michel Maurin, Stéphane Corvaisier, Daniel Claude, Roger Jelliffe, Pascal Maire